{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to MaDu, LLC located at 2025 Broadway, Suite 23E, New York, NY 10023.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/05/04/2021-09332.html","cfr_references":[],"citation":"86 FR 23734","comment_url":null,"comments_close_on":"2021-05-19","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before May 19, 2021 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2021-09332","effective_on":null,"end_page":23735,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/05/04/2021-09332.xml","html_url":"https://www.federalregister.gov/documents/2021/05/04/2021-09332/prospective-grant-of-an-exclusive-patent-license-natural-product-based-nanoparticles-as-dietary","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-09332?publication_date=2021-05-04","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-05-04/2021-09332/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":155,"last_updated":"2026-06-23 22:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-05-04/pdf/2021-09332.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-09332.pdf?1620045931","publication_date":"2021-05-04","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/05/04/2021-09332.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T01:26:29Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":23734,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Natural Product Based Nanoparticles as Dietary Management and/or Treatment of Inflammatory Related Diseases","toc_doc":"Natural Product Based Nanoparticles as Dietary Management and/or Treatment of Inflammatory Related Diseases","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":86}